Mid-Day Market Update: Dow Jumps Over 400 Points; Menlo Therapeutics Shares Plunge
|Midway through trading Wednesday, the Dow traded up 1.51% to 27489.15 while the NASDAQ rose 1.80% to 9126.76. The S&P also rose, gaining 1.49% to 3174.67.
Leading and Lagging Sectors
Information technology shares climbed 2.2% on Wednesday. Meanwhile, top gainers in the sector included Opera Limited OPRA 11.5%, up 15%, and Digital Turbine, Inc APPS 4.54%, up 7%.
In trading on Wednesday, energy shares fell 0.1%.
Top Headline
Lowe's Companies, Inc. LOW 3.7% reported stronger-than-expected earnings for its fourth quarter, while sales missed views. The company also issued weak earnings outlook for FY20.
Lowe's reported quarterly earnings of $0.94 per share, which beat the analyst consensus estimate of $0.91. The company reported quarterly sales of $16.03 billion, which missed the analyst consensus estimate of $16.17 billion.
Lowe's said it expects FY20 adjusted earnings of $6.45 to $6.65 per share, versus analysts’ estimates of $6.67 per share.
Equities Trading UP
SELLAS Life Sciences Group, Inc. SLS 37.92% shares shot up 42% to $2.93 after the company reported follow-up Phase 1/2 clinical data for Galinpepimut-S in acute myeloid leukemia.
Shares of Alpha Pro Tech, Ltd APT 26.24% got a boost, shooting 23% to $12.25 after surging 40% on Tuesday. Alpha Pro Tech expects 'higher than normal' gross margin in Q1 as a result of the Coronavirus.
Tonix Pharmaceuticals Holding Corp. TNXP 161.42% shares were also up, gaining 189% to $1.17 after the company announced a strategic collaboration with Southern Research to support development of a vaccine, codenamed TNX-1800, a live modified horsepox virus vaccine for percutaneous administration, to protect against COVID-19.
Equities Trading DOWN
Aptorum Group Limited APM 52.71% shares tumbled 54% to $6.63 after the company reported the pricing of $10 million registered direct offering.
Shares of SmileDirectClub, Inc. SDC 26.74% were down 26% to $8.39 after the company reported worse-than-expected Q4 results. Jefferies downgraded SmileDirectClub from Buy to Hold and lowered the price target from $22 to $10.
Menlo Therapeutics Inc. MNLO 28.41% was down, falling 25% to $3.2901. Menlo Therapeutics said its Phase 2 study of serlopitant for the treatment of chronic pruritus of unknown origin did not meet the primary endpoint of showing a statistically significant reduction in pruritus in patients treated with serlopitant compared to placebo based upon a 4-point improvement responder analysis.
Commodities
In commodity news, oil traded up 0.1% to $49.92, while gold traded down 0.5% to $1,641.10.
Silver traded down 1.9% Wednesday to $17.855, while copper fell 0.3% to $2.571.
Euro zone
European shares were mixed today. The eurozone’s STOXX 600 dropped 0.21% the Spanish Ibex Index gained 0.49%, while Italy’s FTSE MIB Index gained 1.18% Meanwhile, the German DAX dropped 0.39%, and the French CAC 40 fell 0.17% while UK shares rose 0.18%.
Economics
New home sales rose 7.9% to an annual rate of 764,000 in January.
U.S. crude supplies rose 500,000 barrels for the week ended February 21, the Energy Information Administration reported. However, analysts expected a gain of 2.8 million barrels. Gasoline supplies fell 2.7 million barrels, while distillate supplies declined 2.1 million barrels for the week.
Federal Reserve Bank of Minneapolis President Neel Kashkari will speak at 1:00 p.m. ET.
The Treasury is set to auction 5-year notes at 1:00 p.m. ET.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.